Cargando…
The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
OBJECTIVES: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. METHODS: High-risk proliferative diabetic retinopathy patients undergoi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314316/ https://www.ncbi.nlm.nih.gov/pubmed/28273240 http://dx.doi.org/10.6061/clinics/2017(02)03 |
_version_ | 1782508496947773440 |
---|---|
author | Preti, Rony C Mutti, Anibal Ferraz, Daniel A Zacharias, Leandro C Nakashima, Yoshitaka Takahashi, Walter Y Monteiro, Mario L R |
author_facet | Preti, Rony C Mutti, Anibal Ferraz, Daniel A Zacharias, Leandro C Nakashima, Yoshitaka Takahashi, Walter Y Monteiro, Mario L R |
author_sort | Preti, Rony C |
collection | PubMed |
description | OBJECTIVES: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. METHODS: High-risk proliferative diabetic retinopathy patients undergoing laser treatment were prospectively enrolled in this study. One eye was randomly selected for laser treatment combined with bevacizumab injections, study group, whereas the corresponding eye was subjected to laser treatment alone, control group. Spectral-domain optical coherence tomography with enhanced depth imaging was used to measure the macular choroidal thickness prior to and 1 month after treatment. Measurements in both groups were compared. Clinicaltrials.gov: NCT01389505. RESULTS: Nineteen patients (38 eyes) with a mean±standard deviation age of 53.4±9.3 years were evaluated, and choroidal thickness measurements for 15 patients were used for comparison. The greatest measurement before treatment was the subfoveal choroidal thickness (341.68±67.66 μm and 345.79±83.66 μm for the study and control groups, respectively). No significant difference between groups was found in terms of macular choroidal thickness measurements at baseline or after treatment. However, within-group comparisons revealed a significant increase in choroidal thickness parameters in 10 measurements in the study group and in only 5 temporal measurements in the control group when 1-month follow-up measurements were compared to baseline values. CONCLUSIONS: The macular choroidal thickness does not appear to be significantly influenced by laser treatment alone but increases significantly when associated with bevacizumab injections in patients with proliferative diabetic retinopathy and macular edema. Because bevacizumab injections reduce short-term laser pan-retinal photocoagulation-induced macular edema, our findings suggest that the choroid participates in its pathogenesis. |
format | Online Article Text |
id | pubmed-5314316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo |
record_format | MEDLINE/PubMed |
spelling | pubmed-53143162017-02-17 The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy Preti, Rony C Mutti, Anibal Ferraz, Daniel A Zacharias, Leandro C Nakashima, Yoshitaka Takahashi, Walter Y Monteiro, Mario L R Clinics (Sao Paulo) Clinical Science OBJECTIVES: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. METHODS: High-risk proliferative diabetic retinopathy patients undergoing laser treatment were prospectively enrolled in this study. One eye was randomly selected for laser treatment combined with bevacizumab injections, study group, whereas the corresponding eye was subjected to laser treatment alone, control group. Spectral-domain optical coherence tomography with enhanced depth imaging was used to measure the macular choroidal thickness prior to and 1 month after treatment. Measurements in both groups were compared. Clinicaltrials.gov: NCT01389505. RESULTS: Nineteen patients (38 eyes) with a mean±standard deviation age of 53.4±9.3 years were evaluated, and choroidal thickness measurements for 15 patients were used for comparison. The greatest measurement before treatment was the subfoveal choroidal thickness (341.68±67.66 μm and 345.79±83.66 μm for the study and control groups, respectively). No significant difference between groups was found in terms of macular choroidal thickness measurements at baseline or after treatment. However, within-group comparisons revealed a significant increase in choroidal thickness parameters in 10 measurements in the study group and in only 5 temporal measurements in the control group when 1-month follow-up measurements were compared to baseline values. CONCLUSIONS: The macular choroidal thickness does not appear to be significantly influenced by laser treatment alone but increases significantly when associated with bevacizumab injections in patients with proliferative diabetic retinopathy and macular edema. Because bevacizumab injections reduce short-term laser pan-retinal photocoagulation-induced macular edema, our findings suggest that the choroid participates in its pathogenesis. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2017-02 2017-02 /pmc/articles/PMC5314316/ /pubmed/28273240 http://dx.doi.org/10.6061/clinics/2017(02)03 Text en Copyright © 2017 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited. |
spellingShingle | Clinical Science Preti, Rony C Mutti, Anibal Ferraz, Daniel A Zacharias, Leandro C Nakashima, Yoshitaka Takahashi, Walter Y Monteiro, Mario L R The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
title | The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
title_full | The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
title_fullStr | The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
title_full_unstemmed | The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
title_short | The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
title_sort | effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the oct-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314316/ https://www.ncbi.nlm.nih.gov/pubmed/28273240 http://dx.doi.org/10.6061/clinics/2017(02)03 |
work_keys_str_mv | AT pretironyc theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT muttianibal theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT ferrazdaniela theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT zachariasleandroc theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT nakashimayoshitaka theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT takahashiwaltery theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT monteiromariolr theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT pretironyc effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT muttianibal effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT ferrazdaniela effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT zachariasleandroc effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT nakashimayoshitaka effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT takahashiwaltery effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy AT monteiromariolr effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy |